Agios Pharmaceuticals, Inc. (0HB0)
Market Closed
26 Oct, 03:30 PM
$
37. 64
+0.46
+1.2372%
$
- Market Cap
- P/E Ratio
- Div Yield
83 Volume
- Eps
$ 37.18
Previous Close Want to track 0HB0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Agios Pharmaceuticals, Inc. (0HB0) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.14B
Trailing P/E (ttm) -5.28
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 22.46
Price/Book (mrq) 2.15
Enterprise Value/Revenue 21.77
Enterprise Value/EBITDA -5.14
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 264
Average volume (90 days) 244
Price summary
52-Week low 22.4
52-Week high 45.81
Beta -
50-Day moving average 33.29
200-Day moving average 32.71
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.18%
Operating margin -4.67%
Operational effectiveness
Return on assets -0.37%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.65
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.91
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.38
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 10.22%
Book value per share (mrq) 17.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
